India · Delayed Price · Currency is INR Anthem Biosciences Statistics
Total Valuation
NSE:ANTHEM has a market cap or net worth of INR 529.12 billion. The enterprise value is 522.49 billion.
| Market Cap | 529.12B |
| Enterprise Value | 522.49B |
Important Dates
The last earnings date was Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | Jun 25, 2026 |
Share Statistics
NSE:ANTHEM has 563.20 million shares outstanding. The number of shares has increased by 1.23% in one year.
| Current Share Class | 563.20M |
| Shares Outstanding | 563.20M |
| Shares Change (YoY) | +1.23% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 77.65% |
| Owned by Institutions (%) | 14.43% |
| Float | 98.09M |
Valuation Ratios
The trailing PE ratio is 86.83 and the forward PE ratio is 64.22.
| PE Ratio | 86.83 |
| Forward PE | 64.22 |
| PS Ratio | 25.81 |
| PB Ratio | 16.13 |
| P/TBV Ratio | 16.13 |
| P/FCF Ratio | 99.30 |
| P/OCF Ratio | 70.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 61.18, with an EV/FCF ratio of 98.05.
| EV / Earnings | 85.10 |
| EV / Sales | 25.48 |
| EV / EBITDA | 61.18 |
| EV / EBIT | 72.65 |
| EV / FCF | 98.05 |
Financial Position
The company has a current ratio of 5.53, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.53 |
| Quick Ratio | 3.62 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.08 |
| Interest Coverage | 119.46 |
Financial Efficiency
Return on equity (ROE) is 20.35% and return on invested capital (ROIC) is 21.77%.
| Return on Equity (ROE) | 20.35% |
| Return on Assets (ROA) | 12.90% |
| Return on Invested Capital (ROIC) | 21.77% |
| Return on Capital Employed (ROCE) | 21.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 8.98M |
| Profits Per Employee | 2.69M |
| Employee Count | 2,282 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.91 |
Taxes
In the past 12 months, NSE:ANTHEM has paid 2.35 billion in taxes.
| Income Tax | 2.35B |
| Effective Tax Rate | 27.71% |
Stock Price Statistics
The stock price has increased by +38.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +38.04% |
| 50-Day Moving Average | 885.33 |
| 200-Day Moving Average | 779.63 |
| Relative Strength Index (RSI) | 66.47 |
| Average Volume (20 Days) | 475,913 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ANTHEM had revenue of INR 20.50 billion and earned 6.14 billion in profits. Earnings per share was 10.82.
| Revenue | 20.50B |
| Gross Profit | 13.19B |
| Operating Income | 7.19B |
| Pretax Income | 8.49B |
| Net Income | 6.14B |
| EBITDA | 8.52B |
| EBIT | 7.19B |
| Earnings Per Share (EPS) | 10.82 |
Balance Sheet
The company has 7.05 billion in cash and 411.69 million in debt, with a net cash position of 6.63 billion or 11.78 per share.
| Cash & Cash Equivalents | 7.05B |
| Total Debt | 411.69M |
| Net Cash | 6.63B |
| Net Cash Per Share | 11.78 |
| Equity (Book Value) | 32.81B |
| Book Value Per Share | 58.18 |
| Working Capital | 15.41B |
Cash Flow
In the last 12 months, operating cash flow was 7.55 billion and capital expenditures -2.22 billion, giving a free cash flow of 5.33 billion.
| Operating Cash Flow | 7.55B |
| Capital Expenditures | -2.22B |
| Depreciation & Amortization | 1.33B |
| Net Borrowing | -681.41M |
| Free Cash Flow | 5.33B |
| FCF Per Share | 9.46 |
Margins
Gross margin is 64.35%, with operating and profit margins of 35.08% and 29.95%.
| Gross Margin | 64.35% |
| Operating Margin | 35.08% |
| Pretax Margin | 41.43% |
| Profit Margin | 29.95% |
| EBITDA Margin | 41.54% |
| EBIT Margin | 35.08% |
| FCF Margin | 25.99% |
Dividends & Yields
This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 0.21%.
| Dividend Per Share | 2.00 |
| Dividend Yield | 0.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 18.35% |
| FCF Payout Ratio | 21.14% |
| Buyback Yield | -1.23% |
| Shareholder Yield | -1.01% |
| Earnings Yield | 1.15% |
| FCF Yield | 1.01% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for NSE:ANTHEM is 974.25, which is 3.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 974.25 |
| Price Target Difference | 3.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 19.04% |
| EPS Growth Forecast (3Y) | 20.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |